• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过接种产生完整但无感染性病毒粒子的前病毒DNA,在灵长类动物中有效诱导猿猴免疫缺陷病毒特异性的全身和黏膜免疫反应。

Effective induction of simian immunodeficiency virus-specific systemic and mucosal immune responses in primates by vaccination with proviral DNA producing intact but noninfectious virions.

作者信息

Wang S W, Kozlowski P A, Schmelz G, Manson K, Wyand M S, Glickman R, Montefiori D, Lifson J D, Johnson R P, Neutra M R, Aldovini A

机构信息

Department of Medicine, Children's Hospital, and Department of Pediatrics, Harvard Medical School, Boston, Massachusetts 02115, USA.

出版信息

J Virol. 2000 Nov;74(22):10514-22. doi: 10.1128/jvi.74.22.10514-10522.2000.

DOI:10.1128/jvi.74.22.10514-10522.2000
PMID:11044096
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC110926/
Abstract

We report a pilot evaluation of a DNA vaccine producing genetically inactivated simian immunodeficiency virus (SIV) particles in primates, with a focus on eliciting mucosal immunity. Our results demonstrate that DNA vaccines can be used to stimulate strong virus-specific mucosal immune responses in primates. The levels of immunoglobulin A (IgA) detected in rectal secretions of macaques that received the DNA vaccine intradermally and at the rectal mucosa were the most striking of all measured immune responses and were higher than usually achieved through natural infection. However, cytotoxic T lymphocyte responses were generally low and sporadically present in different animals. Upon rectal challenge with cloned SIVmac239, resistance to infection was observed, but some animals with high SIV-specific IgA levels in rectal secretions became infected. Our results suggest that high levels of IgA alone are not sufficient to prevent the establishment of chronic infection, although mucosal IgA responses may have a role in reducing the infectivity of the initial viral inoculum.

摘要

我们报告了一项在灵长类动物中对产生基因灭活猴免疫缺陷病毒(SIV)颗粒的DNA疫苗进行的初步评估,重点是引发黏膜免疫。我们的结果表明,DNA疫苗可用于刺激灵长类动物产生强烈的病毒特异性黏膜免疫反应。在经皮内和直肠黏膜接种DNA疫苗的猕猴直肠分泌物中检测到的免疫球蛋白A(IgA)水平,是所有测量的免疫反应中最为显著的,且高于通常通过自然感染所达到的水平。然而,细胞毒性T淋巴细胞反应总体较低,且在不同动物中偶尔出现。在用克隆的SIVmac239进行直肠攻击后,观察到了对感染的抵抗力,但一些直肠分泌物中SIV特异性IgA水平较高的动物仍被感染。我们的结果表明,仅高水平的IgA不足以预防慢性感染的建立,尽管黏膜IgA反应可能在降低初始病毒接种物的感染性方面发挥作用。

相似文献

1
Effective induction of simian immunodeficiency virus-specific systemic and mucosal immune responses in primates by vaccination with proviral DNA producing intact but noninfectious virions.通过接种产生完整但无感染性病毒粒子的前病毒DNA,在灵长类动物中有效诱导猿猴免疫缺陷病毒特异性的全身和黏膜免疫反应。
J Virol. 2000 Nov;74(22):10514-22. doi: 10.1128/jvi.74.22.10514-10522.2000.
2
Vaccination of rhesus macaques with a vif-deleted simian immunodeficiency virus proviral DNA vaccine.用缺失vif的猿猴免疫缺陷病毒前病毒DNA疫苗对恒河猴进行接种。
Virology. 2008 May 10;374(2):261-72. doi: 10.1016/j.virol.2008.01.020. Epub 2008 Feb 7.
3
Immunogenicity of a vaccine regimen composed of simian immunodeficiency virus DNA, rMVA, and viral particles administered to female rhesus macaques via four different mucosal routes.四种不同黏膜途径给予雌性恒河猴的猴免疫缺陷病毒 DNA、rMVA 和病毒颗粒疫苗方案的免疫原性。
J Virol. 2013 Apr;87(8):4738-50. doi: 10.1128/JVI.03531-12. Epub 2013 Feb 13.
4
Induction of mucosal protection against primary, heterologous simian immunodeficiency virus by a DNA vaccine.DNA疫苗诱导针对原发性、异源猴免疫缺陷病毒的黏膜保护作用。
J Virol. 2002 Apr;76(7):3309-17. doi: 10.1128/jvi.76.7.3309-3317.2002.
5
Protective immunity to SIV challenge elicited by vaccination of macaques with multigenic DNA vaccines producing virus-like particles.用产生病毒样颗粒的多基因DNA疫苗对猕猴进行接种所引发的针对猴免疫缺陷病毒攻击的保护性免疫。
AIDS Res Hum Retroviruses. 2004 Apr;20(4):425-34. doi: 10.1089/088922204323048177.
6
Both mucosal and systemic routes of immunization with the live, attenuated NYVAC/simian immunodeficiency virus SIV(gpe) recombinant vaccine result in gag-specific CD8(+) T-cell responses in mucosal tissues of macaques.用减毒活疫苗NYVAC/猴免疫缺陷病毒SIV(gpe)重组疫苗进行黏膜免疫和全身免疫,均可在猕猴的黏膜组织中引发针对gag的CD8(+) T细胞应答。
J Virol. 2002 Nov;76(22):11659-76. doi: 10.1128/jvi.76.22.11659-11676.2002.
7
Simian immunodeficiency virus (SIV) gag DNA-vaccinated rhesus monkeys develop secondary cytotoxic T-lymphocyte responses and control viral replication after pathogenic SIV infection.用猿猴免疫缺陷病毒(SIV)gag DNA疫苗接种的恒河猴在感染致病性SIV后会产生继发性细胞毒性T淋巴细胞反应并控制病毒复制。
J Virol. 2000 Aug;74(16):7485-95. doi: 10.1128/jvi.74.16.7485-7495.2000.
8
Humoral immunity induced by mucosal and/or systemic SIV-specific vaccine platforms suggests novel combinatorial approaches for enhancing responses.黏膜和/或全身 SIV 特异性疫苗平台诱导的体液免疫提示了增强反应的新的组合方法。
Clin Immunol. 2014 Aug;153(2):308-22. doi: 10.1016/j.clim.2014.05.008. Epub 2014 Jun 4.
9
Vaccination with Live Attenuated Simian Immunodeficiency Virus (SIV) Protects from Mucosal, but Not Necessarily Intravenous, Challenge with a Minimally Heterologous SIV.用减毒活猴免疫缺陷病毒(SIV)接种可抵御黏膜感染,但不一定能抵御静脉注射感染,这种静脉注射感染来自一种低异源性的SIV。
J Virol. 2016 May 27;90(12):5541-5548. doi: 10.1128/JVI.00192-16. Print 2016 Jun 15.
10
Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.用包裹在纳米颗粒中的Toll样受体配体辅助猿猴免疫缺陷病毒疫苗可诱导持续性抗体反应并增强对TRIM5α限制型猕猴的保护。
J Virol. 2017 Jan 31;91(4). doi: 10.1128/JVI.01844-16. Print 2017 Feb 15.

引用本文的文献

1
Invaplex functions as an intranasal adjuvant for subunit and DNA vaccines co-delivered in the nasal cavity of nonhuman primates.Invaplex作为一种鼻内佐剂,用于在非人灵长类动物鼻腔中共同递送的亚单位疫苗和DNA疫苗。
Vaccine X. 2021 Jun 24;8:100105. doi: 10.1016/j.jvacx.2021.100105. eCollection 2021 Aug.
2
Comparative Evaluation of Prophylactic SIV Vaccination Modalities Administered to the Oral Cavity.口腔途径预防性 SIV 疫苗接种方式的比较评估。
AIDS Res Hum Retroviruses. 2020 Dec;36(12):984-997. doi: 10.1089/AID.2020.0157. Epub 2020 Oct 27.
3
Mucosal Vaccine Approaches for Prevention of HIV and SIV Transmission.预防HIV和SIV传播的黏膜疫苗方法
Curr Immunol Rev. 2019;15(1):102-122. doi: 10.2174/1573395514666180605092054.
4
Maternal HIV-1 Env Vaccination for Systemic and Breast Milk Immunity To Prevent Oral SHIV Acquisition in Infant Macaques.母体接种HIV-1包膜疫苗以获得全身和母乳免疫力,预防幼猴经口感染猿猴-人免疫缺陷病毒。
mSphere. 2018 Jan 10;3(1). doi: 10.1128/mSphere.00505-17. eCollection 2018 Jan-Feb.
5
Persistent Low-Level Replication of SIVΔnef Drives Maturation of Antibody and CD8 T Cell Responses to Induce Protective Immunity against Vaginal SIV Infection.SIVΔnef的持续性低水平复制推动抗体和CD8 T细胞反应成熟,以诱导针对阴道SIV感染的保护性免疫。
PLoS Pathog. 2016 Dec 13;12(12):e1006104. doi: 10.1371/journal.ppat.1006104. eCollection 2016 Dec.
6
Resistance to infection, early and persistent suppression of simian immunodeficiency virus SIVmac251 viremia, and significant reduction of tissue viral burden after mucosal vaccination in female rhesus macaques.雌性恒河猴经黏膜疫苗接种后对感染的抵抗力、猿猴免疫缺陷病毒SIVmac251病毒血症的早期和持续抑制以及组织病毒载量的显著降低。
J Virol. 2014 Jan;88(1):212-24. doi: 10.1128/JVI.02523-13. Epub 2013 Oct 23.
7
Immunogenicity of a vaccine regimen composed of simian immunodeficiency virus DNA, rMVA, and viral particles administered to female rhesus macaques via four different mucosal routes.四种不同黏膜途径给予雌性恒河猴的猴免疫缺陷病毒 DNA、rMVA 和病毒颗粒疫苗方案的免疫原性。
J Virol. 2013 Apr;87(8):4738-50. doi: 10.1128/JVI.03531-12. Epub 2013 Feb 13.
8
Lessons in nonhuman primate models for AIDS vaccine research: from minefields to milestones.艾滋病疫苗研究中非人类灵长类动物模型的教训:从雷区到里程碑。
Cold Spring Harb Perspect Med. 2012 Jun;2(6):a007310. doi: 10.1101/cshperspect.a007310.
9
Envelope-modified single-cycle simian immunodeficiency virus selectively enhances antibody responses and partially protects against repeated, low-dose vaginal challenge.包膜修饰的单周期猴免疫缺陷病毒选择性增强抗体反应,并部分保护免受重复低剂量阴道挑战。
J Virol. 2010 Oct;84(20):10748-64. doi: 10.1128/JVI.00945-10. Epub 2010 Aug 11.
10
Characterization of SIV in the oral cavity and in vitro inhibition of SIV by rhesus macaque saliva.口腔中猴免疫缺陷病毒(SIV)的特征及恒河猴唾液对SIV的体外抑制作用
AIDS Res Hum Retroviruses. 2010 Aug;26(8):901-11. doi: 10.1089/aid.2009.0235.

本文引用的文献

1
Modified wick method using Weck-Cel sponges for collection of human rectal secretions and analysis of mucosal HIV antibody.使用维克-赛尔海绵的改良灯芯法收集人类直肠分泌物并分析黏膜HIV抗体。
J Acquir Immune Defic Syndr. 2000 Aug 1;24(4):297-309. doi: 10.1097/00126334-200008010-00001.
2
Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies.通过被动输注中和抗体保护猕猴免受致病性HIV-1/SIV嵌合病毒的阴道传播。
Nat Med. 2000 Feb;6(2):207-10. doi: 10.1038/72318.
3
Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection.IgG1亚型的人源中和单克隆抗体可预防黏膜猿猴-人类免疫缺陷病毒感染。
Nat Med. 2000 Feb;6(2):200-6. doi: 10.1038/72309.
4
Combined systemic and mucosal immunization with microsphere-encapsulated inactivated simian immunodeficiency virus elicits serum, vaginal, and tracheal antibody responses in female rhesus macaques.
AIDS Res Hum Retroviruses. 1999 Aug 10;15(12):1121-36. doi: 10.1089/088922299310412.
5
Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimen.通过使用多表位基因和DNA初免-修饰安卡拉痘苗病毒加强免疫方案在猕猴中有效诱导猿猴免疫缺陷病毒特异性细胞毒性T淋巴细胞
J Virol. 1999 Sep;73(9):7524-32. doi: 10.1128/JVI.73.9.7524-7532.1999.
6
Beta-chemokine production in macaques vaccinated with live attenuated virus correlates with protection against simian immunodeficiency virus (SIVsm) challenge.接种减毒活病毒的猕猴体内β趋化因子的产生与抵御猿猴免疫缺陷病毒(SIVsm)攻击的保护作用相关。
J Gen Virol. 1999 Jul;80 ( Pt 7):1569-1574. doi: 10.1099/0022-1317-80-7-1569.
7
Highly attenuated vaccine strains of simian immunodeficiency virus protect against vaginal challenge: inverse relationship of degree of protection with level of attenuation.高度减毒的猿猴免疫缺陷病毒疫苗株可抵御阴道攻击:保护程度与减毒水平呈负相关。
J Virol. 1999 Jun;73(6):4952-61. doi: 10.1128/JVI.73.6.4952-4961.1999.
8
Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations.通过DNA初免和重组痘病毒加强免疫实现对免疫缺陷病毒攻击的非中和抗体依赖性遏制
Nat Med. 1999 May;5(5):526-34. doi: 10.1038/8406.
9
Protection from pathogenic SIV challenge using multigenic DNA vaccines.使用多基因DNA疫苗抵御致病性猴免疫缺陷病毒攻击
Immunol Lett. 1999 Mar;66(1-3):183-8. doi: 10.1016/s0165-2478(98)00156-4.
10
Resistance to HIV-1 infection among highly exposed sex workers in Nairobi: what mediates protection and why does it develop?内罗毕高度暴露的性工作者中对HIV-1感染的抵抗力:是什么介导了保护作用,以及为何会产生这种抵抗力?
Immunol Lett. 1999 Mar;66(1-3):27-34. doi: 10.1016/s0165-2478(98)00182-5.